Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Clinical trial NCT04326764 · TERMINATED

Trial details

NCT number: NCT04326764
Sponsor: Goethe University
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Myelodysplastic Syndromes (MDS)

Start date: 2018-07-24
Primary completion: 2023-02-13
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.